Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MacroGenics Inc MGNX

Healthcare Biotechnology
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor... see more

Recent & Breaking News (NDAQ:MGNX)

MacroGenics, Inc. (MGNX) Shareholder Alert: Grabar Law Office Investigates Claims on Your Behalf

Newsfile 13 hours ago

Notice to MacroGenics, Inc. (MGNX) Shareholders: Grabar Law Office Investigates Claims on Your Behalf

Newsfile 8 days ago

Attention Macrogenics, Inc. (MGNX) Shareholders: Grabar Law Office Investigates Potential Claims on Your Behalf

Newsfile 13 days ago

MacroGenics to Participate in Upcoming Investor Conferences

GlobeNewswire November 6, 2024

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

GlobeNewswire November 5, 2024

MacroGenics Announces Leadership Transition

GlobeNewswire October 30, 2024

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

GlobeNewswire October 29, 2024

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Accesswire October 25, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX

PR Newswire September 25, 2024

MGNX DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action - MGNX

Newsfile September 24, 2024

Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNX

Accesswire September 24, 2024

FINAL MGNX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds MacroGenics, Inc. Investors to Join the Class Action Lawsuit!

Newsfile September 24, 2024

Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX)

Accesswire September 24, 2024

The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against MacroGenics, Inc.

Accesswire September 24, 2024

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

Business Wire September 24, 2024

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Newsfile September 24, 2024

FINAL REMINDER MGNX DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts MacroGenics, Inc. Investors to Participate in the Class Action Lawsuit!

Accesswire September 24, 2024

Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGNX

Accesswire September 24, 2024

Final MGNX Deadline Reminder: September 24, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Accesswire September 24, 2024

Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire September 24, 2024